Evaluating effects of treatment in subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers

Am J Cardiol. 1990 Jul 15;66(2):220-2. doi: 10.1016/0002-9149(90)90592-o.

Authors

S Yusuf¹, J Wittes, J Probstfield

Affiliation

¹ Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

PMID: 1973589
DOI: 10.1016/0002-9149(90)90592-o

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial
Comment

MeSH terms

Adrenergic beta-Antagonists / therapeutic use*
Bias
Electrocardiography*
Humans
Myocardial Infarction / drug therapy
Myocardial Infarction / physiopathology*
Propranolol / therapeutic use
Randomized Controlled Trials as Topic

Substances

Adrenergic beta-Antagonists
Propranolol